Literature DB >> 29979225

Variation in Sedation and Neuromuscular Blockade Regimens on Outcome After Cardiac Arrest.

Teresa L May1,2, Richard R Riker1, Gilles L Fraser1, Karen G Hirsch3, Sachin Agarwal4, Christine Duarte5, Hans Friberg6, Eldar Søreide7, John McPherson8, Robert Hand9, David Kent2, Niklas Nielsen10, David B Seder1.   

Abstract

OBJECTIVES: Sedation and neuromuscular blockade protocols in patients undergoing targeted temperature management after cardiac arrest address patient discomfort and manage shivering. These protocols vary widely between centers and may affect outcomes.
DESIGN: Consecutive patients admitted to 20 centers after resuscitation from cardiac arrest were prospectively entered into the International Cardiac Arrest Registry between 2006 and 2016. Additional data about each center's sedation and shivering management practice were obtained via survey. Sedation and shivering practices were categorized as escalating doses of sedation and minimal or no neuromuscular blockade (sedation and shivering practice 1), sedation with continuous or scheduled neuromuscular blockade (sedation and shivering practice 2), or sedation with as-needed neuromuscular blockade (sedation and shivering practice 3). Good outcome was defined as Cerebral Performance Category score of 1 or 2. A logistic regression hierarchical model was created with two levels (patient-level data with standard confounders at level 1 and hospitals at level 2) and sedation and shivering practices as a fixed effect at the hospital level. The primary outcome was dichotomized Cerebral Performance Category at 6 months.
SETTING: Cardiac arrest receiving centers in Europe and the United states from 2006 to 2016 PATIENTS:: Four-thousand two-hundred sixty-seven cardiac arrest patients 18 years old or older enrolled in the International Cardiac Arrest Registry.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The mean age was 62 ± 15 years, 36% were female, 77% out-of-hospital arrests, and mean ischemic time was 24 (± 18) minutes. Adjusted odds ratio (for age, return of spontaneous circulation, location of arrest, witnessed, initial rhythm, bystander cardiopulmonary resuscitation, defibrillation, medical history, country, and size of hospital) was 1.13 (0.74-1.73; p = 0.56) and 1.45 (1.00-2.13; p = 0.046) for sedation and shivering practice 2 and sedation and shivering practice 3, respectively, referenced to sedation and shivering practice 1.
CONCLUSION: Cardiac arrest patients treated at centers using as-needed neuromuscular blockade had increased odds of good outcomes compared with centers using escalating sedation doses and avoidance of neuromuscular blockade, after adjusting for potential confounders. These findings should be further investigated in prospective studies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29979225      PMCID: PMC6138551          DOI: 10.1097/CCM.0000000000003301

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  40 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 2.  Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Clifton W Callaway; Michael W Donnino; Ericka L Fink; Romergryko G Geocadin; Eyal Golan; Karl B Kern; Marion Leary; William J Meurer; Mary Ann Peberdy; Trevonne M Thompson; Janice L Zimmerman
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

3.  Sedation confounds outcome prediction in cardiac arrest survivors treated with hypothermia.

Authors:  Edgar A Samaniego; Michael Mlynash; Anna Finley Caulfield; Irina Eyngorn; Christine A C Wijman
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

4.  Arterial blood pressure and neurologic outcome after resuscitation from cardiac arrest*.

Authors:  J Hope Kilgannon; Brian W Roberts; Alan E Jones; Neil Mittal; Evan Cohen; Jessica Mitchell; Michael E Chansky; Stephen Trzeciak
Journal:  Crit Care Med       Date:  2014-09       Impact factor: 7.598

5.  Continuous versus intermittent neuromuscular blockade in patients during targeted temperature management after resuscitation from cardiac arrest-A randomized, double blinded, double dummy, clinical trial.

Authors:  Mathias Stöckl; Christoph Testori; Fritz Sterz; Michael Holzer; Christoph Weiser; Andreas Schober; Graham Nichol; Martin Frossard; Harald Herkner; Jasmin Kechvar; Heidrun Losert
Journal:  Resuscitation       Date:  2017-08-30       Impact factor: 5.262

Review 6.  Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods.

Authors:  Kees H Polderman; Ingeborg Herold
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

Review 7.  Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.

Authors:  Michael J Murray; Heidi DeBlock; Brian Erstad; Anthony Gray; Judi Jacobi; Che Jordan; William McGee; Claire McManus; Maureen Meade; Sean Nix; Andrew Patterson; M Karen Sands; Richard Pino; Ann Tescher; Richard Arbour; Bram Rochwerg; Catherine Friederich Murray; Sangeeta Mehta
Journal:  Crit Care Med       Date:  2016-11       Impact factor: 7.598

Review 8.  Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system.

Authors:  Michael A Tortorici; Patrick M Kochanek; Samuel M Poloyac
Journal:  Crit Care Med       Date:  2007-09       Impact factor: 7.598

9.  Primary cerebral alveolar echinococcosis: mycology to the rescue.

Authors:  Anne Debourgogne; François Goehringer; Gérald Umhang; Guillaume Gauchotte; Sandrine Hénard; Franck Boué; Thierry May; Marie Machouart
Journal:  J Clin Microbiol       Date:  2013-12-11       Impact factor: 5.948

10.  Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the Intensive Care Unit: executive summary.

Authors:  Juliana Barr; Gilles L Fraser; Kathleen Puntillo; E Wesley Ely; Céline Gélinas; Joseph F Dasta; Judy E Davidson; John W Devlin; John P Kress; Aaron M Joffe; Douglas B Coursin; Daniel L Herr; Avery Tung; Bryce R H Robinson; Dorrie K Fontaine; Michael A Ramsay; Richard R Riker; Curtis N Sessler; Brenda Pun; Yoanna Skrobik; Roman Jaeschke
Journal:  Am J Health Syst Pharm       Date:  2013-01-01       Impact factor: 2.637

View more
  8 in total

1.  Cardiac Arrest Treatment Center Differences in Sedation and Analgesia Dosing During Targeted Temperature Management.

Authors:  Ameldina Ceric; Teresa L May; Anna Lybeck; Tobias Cronberg; David B Seder; Richard R Riker; Christian Hassager; Jesper Kjaergaard; Zana Haxhija; Hans Friberg; Josef Dankiewicz; Niklas Nielsen
Journal:  Neurocrit Care       Date:  2022-07-28       Impact factor: 3.532

2.  Neuromuscular Blockade for Cardiac Arrest Patients Treated With Targeted Temperature Management: A Systematic Review and Meta-Analysis.

Authors:  Tong Lin; Yan Yao; Yuan Xu; Hui-Bin Huang
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

3.  European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care.

Authors:  Jerry P Nolan; Claudio Sandroni; Bernd W Böttiger; Alain Cariou; Tobias Cronberg; Hans Friberg; Cornelia Genbrugge; Kirstie Haywood; Gisela Lilja; Véronique R M Moulaert; Nikolaos Nikolaou; Theresa Mariero Olasveengen; Markus B Skrifvars; Fabio Taccone; Jasmeet Soar
Journal:  Intensive Care Med       Date:  2021-03-25       Impact factor: 17.440

Review 4.  Targeted temperature management and early neuro-prognostication after cardiac arrest.

Authors:  Songyu Chen; Brittany Bolduc Lachance; Liang Gao; Xiaofeng Jia
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-14       Impact factor: 6.200

5.  Association Between Target Temperature Variability and Neurologic Outcomes for Patients Receiving Targeted Temperature Management at 36°C After Cardiac Arrest: A Retrospective Cohort Study.

Authors:  Makayla Cordoza; Hilaire Thompson; Elizabeth Bridges; Robert Burr; David Carlbom
Journal:  Ther Hypothermia Temp Manag       Date:  2020-06-16       Impact factor: 1.369

6.  Continuous neuromuscular blockade infusion for out-of-hospital cardiac arrest patients treated with targeted temperature management: A multicenter randomized controlled trial.

Authors:  Byung Kook Lee; In Soo Cho; Joo Suk Oh; Wook Jin Choi; Jung Hee Wee; Chang Sun Kim; Won Young Kim; Chun Song Youn
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

7.  Consensus Statement on Analgo-sedation in Neurocritical Care and Review of Literature.

Authors:  Hemanshu Prabhakar; Swagata Tripathy; Nidhi Gupta; Vasudha Singhal; Charu Mahajan; Indu Kapoor; Jaya Wanchoo; Mani Kalaivani
Journal:  Indian J Crit Care Med       Date:  2021-02

8.  High Quality Targeted Temperature Management (TTM) After Cardiac Arrest.

Authors:  Fabio Silvio Taccone; Edoardo Picetti; Jean-Louis Vincent
Journal:  Crit Care       Date:  2020-01-06       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.